Intrinsic Value of S&P & Nasdaq Contact Us

Merck & Co., Inc. MRK NYSE

NYSE • Healthcare • Drug Manufacturers - General • US • USD

SharesGrow Score
83/100
7/7 Pass
SharesGrow Intrinsic Value
$187.77
+56.5%
Analyst Price Target
$128.54
+7.2%
SharesGrow 7-Criteria Score All 7 criteria scored · income-related highlighted on this page

Merck & Co., Inc. (MRK) reported moderate year-over-year revenue growth of +1.3% through 2025-12 (TTM revenue vs prior-year TTM). Net income showed solid earnings growth of +6.6% YoY, reaching $3.0B in the latest quarter. The net profit margin is 18.1%, which is high. The company has maintained profitability in all 4 quarters. The gross margin is 81.5% (high), up 0.5pp vs the prior year. With a $297B market cap, MOAT composite score of 90/100 (strong competitive position).

Criteria proven by this page:

  • GROWTH (73/100, Partial) — growth is present but not consistently above 5% across both metrics
  • PAST (100/100, Pass) — proving consistent earnings. Looking at the full 41-year annual history, the company was profitable in 41 of 41 years — a perfect long-term track record
  • INCOME (85/100, Pass) — proves strong profitability and pricing power
  • MOAT (90/100, Pass) — strong gross margins and market scale prove a durable competitive advantage

Overall SharesGrow Score: 83/100 with 7/7 criteria passed.

83/100
SG Score
View full scorecard →
VALUE
84/100
Price-to-Earnings & upside
→ IV page
FUTURE
61/100
Analyst consensus
→ Forecast
PAST
100/100
4/4 qtrs profit
EPS $1.19
Proven by this page
HEALTH
83/100
Debt-to-Equity & liquidity
→ Health
MOAT
94/100
Score: 90/100
GM 81.5% (+0.5pp)
Proven by this page
GROWTH
73/100
Rev +1.3% YoY
NI +6.6% YoY
Proven by this page
INCOME
85/100
Margin 18.1%
$16.4B
Proven by this page
Merck & Co., Inc. Earnings and Revenue History
Revenue
Earnings & Profit Margin
Metric TTM Q4 FY2025 Q3 FY2025 Q2 FY2025 Q1 FY2025
Revenue $65.01B$16.4B$17.28B$15.81B$15.53B
Gross Profit $52.98B$15.2B$13.42B$12.25B$12.11B
Gross Margin 81.5%92.7%77.7%77.5%78%
Operating Income $26.78B$8.74B$6.55B$5.55B$5.94B
Net Income $18.25B$2.96B$5.79B$4.43B$5.08B
Net Margin 28.1%18.1%33.5%28%32.7%
EPS (Diluted) $7.28$1.19$2.32$1.76$2.01
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message